Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Part 1 – Case Presentation Brian A. Jonas, MD, PhD, FACP, presents the case of patient “J.S.” to fellow faculty members Daniel A. Pollyea, MD, MS, and Gabriel…
Part 2 – Case Discussion Brian A. Jonas, MD, PhD, FACP, presents the case of patient “J.S.” to fellow faculty members Daniel A. Pollyea, MD, MS, and Gabriel…
Part 3 – Case Discussion & Wrap-up Brian A. Jonas, MD, PhD, FACP, presents the case of patient “J.S.” to fellow faculty members Daniel A. Pollyea, MD, MS,…
Part 1 – Case Presentation Brian A. Jonas, MD, PhD, FACP, presents the case of patient “A.B.” to fellow faculty members Daniel A. Pollyea, MD, MS and Gabriel…
Part 2 – Case Discussion Brian A. Jonas, MD, PhD, FACP, presents the case of patient “A.B.” to fellow faculty members Daniel A. Pollyea, MD, MS and Gabriel…
Part 3 – Case Discussion & Wrap-up Brian A. Jonas, MD, PhD, FACP, presents the case of patient “A.B.” to fellow faculty members Daniel A. Pollyea, MD, MS…
Anne S. De Groot, MD, of EpiVax, Inc., and the Center for Vaccines and Immunology, University of Georgia, and colleagues present a study designed to develop a #tool…
